customer login
InoveonIfa Systems AG

INOVEON Corporation is the proven expert in detection, staging, and monitoring of diabetic retinopathy and macular edema. We help group practices create and manage a completely turnkey on-site system. The benefit is that physicians in a variety of settings can easily implement the gold standard of quality care developed by the National Institutes of Health and used in the DCCT - right in their own day-to-day practice.



iScan

Diabetic retinal imaging process according to the ETDRS "Gold Standard" for 7-field stereo fundus photography.

read more


iContact

Working with physicians, we create and seamlessly integrate the iContact patient communications program that reaches out to patients for scheduling their annual evaluations. Our experience shows this not only increases compliance, but also patients' positive feelings of satisfaction about their diabetic care.

read more


iScore

Reading experts use specialized software to evaluate 3-D images of the eye to assign diabetic retinopathy disease scores (like the one used in the DCCT). A standard, easy-to-read report is generated for each study and returned to the ordering physician within 48 hours.

read more


iSite

Patients access the iScan™ procedure at an iSite™ Center conveniently placed in their usual diabetes care setting. In addition, with Inoveon's OnSite iScan, you can extend the highest quality teleretinal imaging services to outlying clinics without the need for dedicated space or equipment.

read more

iScan


A trained technician performs an iScan™ procedure including visual acuity measurement, pupil dilation, intraocular pressure measurement, and multi-field color stereoscopic digital retinal imaging. The iScan™ procedure represents a digital implementation of the NIH gold standard as defined in the DCCT trials. It is the only clinically validated scale for detecting, staging and monitoring DR and DME. In fact, it offers 98% sensitivity, 90% specificity and 99% negative predictive value. Digital images are electronically and securely sent to a centralized reading facility for evaluation by trained experts. With over 100,000 iScans performed, we offer the most experienced service of its kind.

iContact


Turn-key scheduling and data management solution, utilizing your patient scheduling and records systems. • Avg. annual camera utilization: > 2400 patients • Avg. appointment follow-through: > 75% • Avg. patient compliance: > 90 %

iScore


A standard, easy-to-read report is generated for each study and returned to the ordering physician within 48 hours. The report is color coded for easy recognition of patients that require more careful monitoring (yellow) or ophthalmic referral (red) from those that can be routinely monitored on a yearly basis (green). Inoveon's 10-step scale is adapted from ETDRS Report Number 12 (Ophthalmology 1991;98:823-33).

iSite


In keeping with diabetes-care guidelines, physicians refer patients for their annual retinal evaluations. Patients access the iScan™ procedure at an iSite™ Center conveniently placed in their usual diabetes care setting. Our turnkey service puts "gold standard" retinal evaluations in the convenience of the primary care practice to accurately detect, stage and monitor both diabetic retinopathy and macular edema. That means primary care physicians can perform the same level of exam as in the DCCT, they can meet HEDIS guidelines for annual testing, and they can achieve high patient satisfaction scores. It also facilitates patient compliance